• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

OrbiMed Advisors

edit

OrbiMed is ahealthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed’s investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds.

Milestones

edit

• 
  OrbiMed Advisors invested in Roka Bioscience. (1/8/12)
  Posted 1/8/12 at 7:22pm via prnewswire.com
• 
  OrbiMed Advisors invested in arGEN-X. (12/1/11)
  Posted 12/1/11 at 5:11am via finsmes.com
• 
  OrbiMed Advisors invested in Rempex Pharmaceuticals. (11/9/11)
  Posted 11/9/11 at 9:22pm via rempexpharma.com
• 
  OrbiMed Advisors invested in DFine. (11/8/11)
  Posted 11/8/11 at 9:10pm via finsmes.com
• 
  OrbiMed Advisors invested in Arteaus Therapeutics. (10/19/11)
  Posted 10/19/11 at 5:49pm via finsmes.com
• 
  OrbiMed Advisors invested in Cleave Biosciences. (10/11/11)
  Posted 10/11/11 at 7:32pm via finsmes.com
• 
  OrbiMed Advisors invested in ViewRay. (9/2/11)
  Posted 9/1/11 at 10:14pm via wraltechwire.com
• 
  OrbiMed Advisors invested in Vessix Vascular. (8/3/11)
  Posted 8/3/11 at 6:27pm via finsmes.com
• 
  OrbiMed Advisors invested in Roka Bioscience. (7/28/11)
  Posted 7/28/11 at 6:18pm via finsmes.com
• 
  OrbiMed Advisors invested in Ambit Biosciences. (6/10/11)
  Posted 6/10/11 at 6:24pm via ambitbio.com
• 
  OrbiMed Advisors invested in Biodel. (5/13/11)
  Posted 5/13/11 at 6:19pm via masshightech.com
• 
  OrbiMed Advisors invested in Crown Bioscience. (5/4/11)
  Posted 5/4/11 at 5:59am via equityhelpdesk.com
• 
  OrbiMed Advisors invested in SMT Research and Development. (4/3/11)
  Posted 4/5/11 at 7:46pm via co.il
• 
  OrbiMed Advisors invested in Arsanis. (2/28/11)
  Posted 2/8/11 at 7:32pm via news-medical.net
• 
  OrbiMed Advisors invested in Bonovo Orthopedics. (12/23/10)
  Posted 12/23/10 at 8:19pm via bonovo-ortho.com
• 
  OrbiMed Advisors invested in Anthera Pharmaceuticals. (9/21/10)
  Posted 10/31/10 at 7:06pm via anthera.com

Investments

Videos

Sources

1. OrbiMed Advisors Raises $312M Toward New Venture Fund (fis.dowjones.com) [edit]
2. Gov't, Orbimed launch biomed fund (globes.co.il) [edit]
3. OrbiMed launches $600M fund for royalty, debt deals (fiercebiotech.com) [edit]
4. Roka Bioscience Secures $47.5 Million in Series D Financing (prnewswire.com) [edit]
5. arGEN-X Closes €27.5M Series B Funding Round (finsmes.com) [edit]
6. Rempex Announces Series B Financing of up to $67.5 Million (rempexpharma.com) [edit]
7. DFINE Closes $25M Equity Financing (finsmes.com) [edit]
8. Arteaus Therapeutics Raises $18M in Funding (finsmes.com) [edit]
9. Cleave Biosciences Raises $42M in Series A Financing (finsmes.com) [edit]
10. MRI-guided radiotherapy firm ViewRay gets $10M in new funding (wraltechwire.com) [edit]
11. Vessix Vascular Completes $23M Series B Financing (finsmes.com) [edit]
12. Roka Bioscience Completes $20M Series C Equity Financing (finsmes.com) [edit]
13. AMBIT BIOSCIENCES COMPLETES $30 MILLION SERIES D-2 FINANCING (ambitbio.com) [edit]
14. Connecticut’s Biodel plans to raise $30M (masshightech.com) [edit]
15. Crown Bioscience Closes $28.8M Series C Financing Round (equityhelpdesk.com) [edit]
16. Brain clot protection co SMT raises $10.5m (globes.co.il) [edit]
17. Arsanis closes Series A financing for $10 million (news-medical.net) [edit]
18. Bonovo Orthopedics, Inc. Closes Series C Financing Led by OrbiMed Asia Partners (bonovo-ortho.com) [edit]
19. Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing (investor.anthera.com) [edit]
20. Eddingpharm (Cayman) Closes $24M Series B Funding (finsmes.com) [edit]
21. Relypsa Raises $70M in Series B Financing (finsmes.com) [edit]
22. Good Start Genetics, Inc. Raises $18 Million to Develop and Launch Sequencing‐Based Pre‐Pregnancy Genetic Screening Test (goodstartgenetics.com) [edit]
23. superDimension Raises $24.8 Million in Debt and Equity Financing (superdimension.com) [edit]
24. ViewRay Secures Series C Financing (viewray.com) [edit]
25. Complete Genomics, Inc. Announces Completion of $39 Million Series E Financing (completegenomics.com) [edit]
26. Cerenis Therapeutics raises EUR 40 million in series C financing (cerenis.com) [edit]
27. DFine raises $36.2M to repair spine fractures (deals.venturebeat.com) [edit]
28. Acceleron Pharma pulls in $8.4M financing (masshightech.com) [edit]
29. Igenica, Inc.: Series B $24M (onbiovc.com) [edit]
30. Aragon Pharma readies first cancer trial after $22M B round (fiercebiotech.com) [edit]
31. SELECTA CLOSES $15 MILLION SERIES C FINANCING (freshnews.com) [edit]
32. Adimab, Inc.: Series D $8.2M (onbiovc.com) [edit]
33. OrbiMed Makes First Indian Investment Through Pan Asia Fund (fis.dowjones.com) [edit]
34. PharmAbcine Closes USD $6 Million Series A Financing (bio-medicine.org) [edit]
35. Complete Genomics bags $45M round for sequencing (fiercebiotech.com) [edit]
36. Enobia Raises US$50M from Current Investors in Series C Financing (enobia.com) [edit]
37. Aragon Pharmaceuticals, Inc.: Series A $8M (onbiovc.com) [edit]
38. CeraPedics, Inc. Raises $15 Million (devicespace.com) [edit]
39. Singulex Closes $19 Million Financing Round (bio-medicine.org) [edit]
40. Adimab, Inc. Announces Series C Financing (adimab.com) [edit]
41. ARYx Therapeutics Inc. Announces $21.6 Million Private Placement (investors.aryx.com) [edit]
42. Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C (mitsuiventures.com) [edit]
43. Innovative Spinal Technologies Jilted, Now Bankrupt, Source Says (xconomy.com) [edit]
44. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
45. InteKrin raises $18.5M for continued work on diabetes drug (deals.venturebeat.com) [edit]
46. SGX Pharmaceuticals raises $25 million: SGX Pharmaceuticals Inc. (thefreelibrary.com) [edit]
47. enobia.com [edit]
48. Agensys Raises $41 Million (agensys.com) [edit]
49. Cap Funding Report [edit]
50. Biomarker-diagnostics developer Singulex validates $19M (venturebeat.com) [edit]
51. Sientra, device maker for plastic surgery, raises $85M (deals.venturebeat.com) [edit]
52. ChemoCentryx, autoimmune disease drug co., raises $29.84M (deals.venturebeat.com) [edit]
53. CeraPedics Closes $12.25M PE Financing (rnaventures.blogspot.com) [edit]
54. Cap Funding Report [edit]
55. ChemoCentryx Completes Series C Financing (chemocentryx.com) [edit]
56. Acceleron Pharma Closes $30M Series B Financing (acceleronpharma.com) [edit]
57. MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs (macrogenics.com) [edit]
58. ARIUS Closes US$21.5 Million Financing (business.highbeam.com) [edit]
59. Amnis Closes Oversubscribed $11.25M Series C Round (integraventures.net) [edit]
60. Adiana, Inc. Reports Completion of $23 Million Financing. (allbusiness.com) [edit]
61. Cap Funding Report [edit]
62. ChemoCentryx Raises $33 Million in Private Financing (chemocentryx.com) [edit]